Remove Pharma Companies Remove Pharma Production Remove Regulation Remove Sales
article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Although medicines tend to be excluded from trade sanctions as they cause loss of life, Russian pharma companies may struggle to secure funding in the face of economic sanctions and there may also be a disruption to non-essential medicines. million vaccine doses upon EMA authorisation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.

article thumbnail

How pharmaceutical firms are making their supply chains more efficient

Pharmaceutical Technology

Dealing with different regulations and stakeholders across diverse regions means there are many points in the journey where something can go wrong. Given these potential vulnerabilities, visibility is essential for organisations seeking to accurately track their products and ensure they are safe to use.